PACIRA BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.69 USD | +0.27% |
|
+13.00% | -56.46% |
| Sep. 09 | Pacira Biosciences, Inc. Announces Board Changes | CI |
| Aug. 13 | Truist Securities Downgrades Pacira BioSciences to Sell From Buy, Adjusts Price Target to $8 From $30 | MT |
Main competitors
| 1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 8 | |||||||||
| 25 | |||||||||
| 26 | |||||||||
| 22 | |||||||||
| 27 | |||||||||
| 26 | |||||||||
| 19 | |||||||||
| 20 | |||||||||
| 20 | |||||||||
| 24 | |||||||||
| 22 | |||||||||
| 22 | |||||||||
| 27 | |||||||||
| 21 | |||||||||
| 21 | |||||||||
| 15 | |||||||||
| 17 | |||||||||
| 17 | |||||||||
| 18 | |||||||||
| Average | 21 | ||||||||
| Weighted average by Cap. | 23 |
- Stock Market
- Equities
- PCRX Stock
- Sector Pacira BioSciences, Inc.
- Sector revisions
